I-Mab at Jefferies London Healthcare Conference TranscriptNov 14, 2023- Half Year 2023 I-Mab Earnings Call TranscriptAug 17, 2023$2.3 (-2.95%)Earnings
- Full Year 2022 I-Mab Earnings Call TranscriptMar 31, 2023$3.46 (-1.70%)Earnings
- I-Mab Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab Call TranscriptSep 12, 2022
- Half Year 2022 I-Mab Earnings Call TranscriptAug 30, 2022$5.98 (+2.57%)Earnings
- I-Mab R&D Day TranscriptJul 20, 2022
- I-Mab TJD5 Phase 2 Clinical Trial Data Update Call TranscriptMay 27, 2022
- Full Year 2021 I-Mab Earnings Call TranscriptMar 29, 2022$19.39 (+15.07%)Earnings
- I-Mab at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- I-Mab Corporate Call TranscriptDec 21, 2021
- I-Mab Most Recent Clinical Data Update Conference Call -- English Session TranscriptDec 14, 2021
- I-Mab and Jumpcan To Announce its Strategic Commercial Partnership on Eftansomatropin Alfa - Special Call TranscriptNov 10, 2021
- Half Year 2021 I-Mab Earnings & Corporate Progress Update Conference Call TranscriptAug 31, 2021
- I-Mab to Discuss Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021 Call TranscriptJun 07, 2021
- I-Mab at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- I-Mab Corporate Analyst Meeting TranscriptApr 26, 2021
- Full Year 2020 I-Mab Earnings Call TranscriptMar 29, 2021$44.38 (-4.80%)Earnings
- IMAB Lemzoparlimab Phase 1 Clinical Trial Data Update Conference Call TranscriptNov 13, 2020
- I-Mab SITC Data Conference Call TranscriptNov 09, 2020
- I-Mab Company Update Conference Call TranscriptSep 04, 2020
- Half Year 2020 I-Mab Earnings Call TranscriptAug 31, 2020$39.44 (+27.23%)Earnings
- I-Mab Update Conference Call TranscriptMay 28, 2020
- I-Mab at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Full Year 2019 I-Mab Earnings Call TranscriptMar 31, 2020$13 (+4.00%)Earnings
I-Mab SITC Data Conference Call Transcript
Hello, and welcome to the I-Mab Company Update Conference Call. (Operator Instructions) Please note, today's event is being recorded.
I would now like to turn the conference over to your host today, Leah Liu. Please go ahead, ma'am.
Hi, everyone. This is Leah. I'm the IR Director for I-Mab. Welcome to the call, and thank you for joining us.
On the call today, we have our Founder and Chairman, Dr. Jingwu Zang; our CEO, Dr. Joan Shen; our CFO, Mr. Jielun Zhu; and our U.S. Site Head and the Project Lead for our lemzoparlimab project in the U.S., Claire Xu.
So I guess without further ado, I'll hand over the mic to Dr. Zang to give you a description on our recently released -- well, just released data at SITC on our U.S. project for lemzoparlimab. So Dr. Zang?
Thank you, Leah. First of all, I'd like to thank you all for joining us today for this call. We are very pleased to present and to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
